Analysing the efficacy of treatment through Response Evaluation Criteria in Soli...
Dr Yves Menu – Saint Antoine Hospital, Paris, France
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )
9 Oct 2012
Highlights of the 22nd EACR meeting and tackling glioblastoma
Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Highlights of the 22nd EACR meeting and tackling glioblastoma ( Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
16 Jul 2012
Combined chemo-radiation extends survival for anaplastic oligodendroglial tumour...
Prof Martin van den Bent - Erasmus University Medical Center, Rotterdam, The Net...
Combined chemo-radiation extends survival for anaplastic oligodendroglial tumours ( Prof Martin van den Bent - Erasmus University Medical Center, Rotterdam, The Netherlands )
20 Jun 2012
Combined chemo-radiation extends survival in patients with anaplastic oligodendr...
Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam, Netherlan...
Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours ( Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam, Netherlands )
3 Jun 2012
Developing new support services for young people with cancer
Prof Daniel Kelly - Cardiff University, UK and EONS
Developing new support services for young people with cancer ( Prof Daniel Kelly - Cardiff University, UK and EONS )
10 May 2012
Brain development in foetus during cancer treatment
Dr Monica Fumagalli - Fondazione IRCCS Ca' Granada Ospedale Maggiore Policlinico...
Brain development in foetus during cancer treatment ( Dr Monica Fumagalli - Fondazione IRCCS Ca' Granada Ospedale Maggiore Policlinico, Milan, Italy )
27 Apr 2012
EGFR mutation unique to glioblastoma linked to lack of response
Dr Ingo Mellinghoff - Memorial Sloan-Kettering Cancer Center, New York, USA
EGFR mutation unique to glioblastoma linked to lack of response ( Dr Ingo Mellinghoff - Memorial Sloan-Kettering Cancer Center, New York, USA )
13 Apr 2012
Roundup of the EMCC 2011 conference
Prof Gordon McVie - European Institute of Oncology and ecancer
Roundup of the EMCC 2011 conference ( Prof Gordon McVie - European Institute of Oncology and ecancer )
3 Oct 2011
Genetic mutations as causes of cancer
Dr Henry Lynch - Creighton University, Omaha, USA
Genetic mutations as causes of cancer ( Dr Henry Lynch - Creighton University, Omaha, USA )
25 Sep 2011
The P-Medicine project; data sharing and integration for personalised medicine
Dr Simona Rossi - Swiss Institute for Bioinformatics, Lausanne, Switzerland
The P-Medicine project; data sharing and integration for personalised medicine ( Dr Simona Rossi - Swiss Institute for Bioinformatics, Lausanne, Switzerland )
14 Jul 2011
ASCO 2011: Developments in ovarian cancer therapy
Prof Christian Marth - Innsbruck Medical University, Austria
ASCO 2011: Developments in ovarian cancer therapy ( Prof Christian Marth - Innsbruck Medical University, Austria )
23 Jun 2011
Optimal therapy for children with high risk ALL
Dr Eric Larsen - Maine Children’s Cancer Program, Portland, USA
Optimal therapy for children with high risk ALL ( Dr Eric Larsen - Maine Children’s Cancer Program, Portland, USA )
23 Jun 2011